|
Growth factors/cytokines
Citations 91-100 of 140 total displayed.
|
Past content
(since Jan 1999):
|
- Scientific Contributions
Cyclooxygenase-2 Inhibition Attenuates Lipopolysaccharide-Induced Cardiovascular Failure
- Klaus Höcherl, Franziska Dreher, Armin Kurtz, and Michael Bucher
Hypertension 2002;40:947-953; published online before print as doi:10.1161/01.HYP.0000041221.13644.B9
[Abstract]
[Full text]
- Scientific Contributions
Antiinflammatory and Antiarteriosclerotic Effects of Pioglitazone
- Minako Ishibashi, Kensuke Egashira, Ken-ichi Hiasa, Shujiro Inoue, Weihua Ni, Qingwei Zhao, Makoto Usui, Shiro Kitamoto, Toshihiro Ichiki, and Akira Takeshita
Hypertension 2002;40:687-693; published online before print as doi:10.1161/01.HYP.0000036396.64769.C2
[Abstract]
[Full text]
- Scientific Contributions
Angiotensin II Triggers EGFR Tyrosine Kinase-Dependent Ca2+ Influx in Afferent Arterioles
- Qi Che and Pamela K. Carmines
Hypertension 2002;40:700-706; published online before print as doi:10.1161/01.HYP.0000035524.10948.93
[Abstract]
[Full text]
- Scientific Contributions
Cyclooxygenase-2 Inhibition Attenuates Lipopolysaccharide-Induced Cardiovascular Failure
- Klaus Höcherl, Franziska Dreher, Armin Kurtz, and Michael Bucher
Hypertension published October 28, 2002, doi:10.1161/01.HYP.0000041221.13644.B9
[Abstract]
- Scientific Contributions
Endothelin-Converting Enzyme Inhibition
Ameliorates Angiotensin II-Induced Cardiac
Damage
- Dominik N. Muller, Alexander Mullally, Ralf Dechend, Joon-Keun Park, Anette Fiebeler, Bernhard Pilz, Bernd-Michael Löffler, Denise Blum-Kaelin, Stefan Masur, Henrietta Dehmlow, Johannes D. Aebi, Hermann Haller, and Friedrich C. Luft
Hypertension published October 21, 2002, doi:10.1161/01.HYP.0000039748.88581.A0
[Abstract]
- Scientific Contributions
Antiinflammatory and Antiarteriosclerotic Effects of Pioglitazone
- Minako Ishibashi, Kensuke Egashira, Ken-ichi Hiasa, Shujiro Inoue, Weihua Ni, Qingwei Zhao, Makoto Usui, Shiro Kitamoto, Toshihiro Ichiki, and Akira Takeshita
Hypertension published September 30, 2002, doi:10.1161/01.HYP.0000036396.64769.C2
[Abstract]
- Scientific Contributions
Angiotensin II Triggers EGFR Tyrosine Kinase-Dependent Ca2+ Influx in Afferent Arterioles
- Qi Che and Pamela K. Carmines
Hypertension published September 23, 2002, doi:10.1161/01.HYP.0000035524.10948.93
[Abstract]
- Scientific Contributions
KDR (VEGF Receptor 2) Is the Major Mediator for the Hypotensive Effect of VEGF
- Bing Li, Annie K. Ogasawara, Renhui Yang, Wei Wei, Guo-Wei He, Thomas F. Zioncheck, Stuart Bunting, Abraham M. de Vos, and Hongkui Jin
Hypertension 2002;39:1095-1100, doi:10.1161/01.HYP.0000018588.56950.7A
[Abstract]
[Full text]
- Scientific Contributions
Catecholamines Block 2-Hydroxyestradiol-Induced Antimitogenesis in Mesangial Cells
- Lefteris C. Zacharia, Edwin K. Jackson, Delbert G. Gillespie, and Raghvendra K. Dubey
Hypertension 2002;39:854-859, doi:10.1161/01.HYP.0000014502.44988.39
[Abstract]
[Full text]
- Scientific Contributions
Nitric Oxide, Anti-Inflammatory Drugs on Renal Prostaglandins and Cyclooxygenase-2
- Masaru Miyataka, Kathryn A. Rich, Marylou Ingram, Tadahiko Yamamoto, and Richard J. Bing
Hypertension 2002;39:785-789, doi:10.1161/hy0302.105689
[Abstract]
[Full text]
|
|